Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
NB-UVB phototherapy plays a key role in psoriasis treatment, expert says
Home phototherapy booths provide a safe and effective way to use NB-UVB phototherapy while minimizing copays and commuting costs.
News
Which solid organ transplant recipients face the highest risk of skin cancer?
Those at low risk for skin cancer include abdominal organ recipients, SOTR age of younger than 50 at time of transplant, and female gender.
News
Hair loss: Consider a patient’s supplement use
Insufficient data exist to recommend supplementation with zinc, riboflavin, folic acid, or vitamin B12 for hair loss, “but they may...
News
PLA testing brings nuance to the diagnosis of early-stage melanoma
“Future prospective randomized clinical trials are needed to examine role of genetic expression profiling in staging and managing patients,” Dr....
News
Photoprotection strategies for melasma are increasing
A guide to tinted sunscreens published in December 2021 recommended that consumers choose a product that contains iron oxides, is labeled as broad...
News
Global registry tracks COVID-19 outcomes in atopic dermatitis patients
Dupilumab monotherapy was associated with lower odds of hospitalizations compared with other therapies.
News
Novel isotretinoin ointment for congenital ichthyosis shows promise
“There is currently no FDA-approved drug for congenital ichthyosis,” Dr. Christopher G. Bunick said.
News
COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
“Our theory is that the severe inflammatory nature of COVID-19 leads to a lot of internal organ damage and exposure of autoantigens in that...
News
Topical options for treating melasma continue to expand
“We have to tell our patients that melasma therapy is a journey of skin lightening but it’s not going to be a one-stop shop of getting it...
News
Q&A With JAAD Editor Dirk M. Elston, MD
“We are in a golden age of therapeutic innovations that are life changing and lifesaving for our patients,” Dr. Dirk M. Elston said.
News
Why is there an increased risk of cancer in depressed patients?
“We have to think about depression as a systemic illness,” Dr. Charles B. Nemeroff said. “What is depression doing that’s creating a fertile...
News
Routine pharmacogenetic testing in psychiatry not indicated
“Whether or not the science supports it, we’re going to have to interpret these reports and explain them to our patients,” said Dr. Erika Nurmi....
News
Self-care tips for clinicians as COVID-19 lingers
“We want to promote psychological flexibility: the ability to stay in contact with the present moment,” Dr. Jon A. Levenson said.
News
The importance of a post-COVID wellness program for medical staff
“We want to promote the message that emotional health should have the same priority level as physical health,” Dr. Jon A. Levenson said.
News
When is your patient a candidate for ECT?
An emerging adjunct to ECT is cervical invasive vagus nerve stimulation (VNS) therapy, according to Dr. Mark S. George.